Ionis Pharmaceuticals saw the highest growth of 1.74% in patent filings in May and 0.86% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.61% and grants by 0.86%. GlobalData’s DataBook provides a comprehensive analysis of Ionis Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Ionis Pharmaceuticals has been focused on protecting inventions in United States(US) with 16 publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 37% filings and 38% grants. The United States(US), European Patent Office(EPO), Israel(IL), and South Korea(KR) patent Office are among the top ten patent offices where Ionis Pharmaceuticals is filings its patents. Among the top granted patent authorities, Ionis Pharmaceuticals has 38% of its grants in United States(US), 31% in China(CN) and 15% in European Patent Office(EPO).

Arrowhead Pharmaceuticals and Roche could be the strongest competitors for Ionis Pharmaceuticals

Patents related to rare diseases and addiction lead Ionis Pharmaceuticals's portfolio

Ionis Pharmaceuticals has the highest number of patents in rare diseases followed by, addiction and climate change. For rare diseases, nearly 89% of patents were filed and 83% of patents were granted in Q2 2024.

Epilepsy related patents lead Ionis Pharmaceuticals portfolio followed by ataxia, and non-alcoholic steatohepatitis (nash)

Ionis Pharmaceuticals has highest number of patents in epilepsy followed by ataxia, non-alcoholic steatohepatitis (nash), seizures, and liver diseases.

For comprehensive analysis of Ionis Pharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.